What question did this study set out to answer?

To assess the impact of rapid antimicrobial susceptibility testing on therapeutic outcomes in bloodstream infections.

June 14, 2026The AnalystOpen Access

Rapid Antimicrobial Susceptibility Testing in Bloodstream Infections: Current Landscape and Emerging Technologies

View Full Paper

Ask AI

Bookmark

To assess the impact of rapid antimicrobial susceptibility testing on therapeutic outcomes in bloodstream infections.
Analyzed various rapid diagnostic techniques for bloodstream infections
Evaluated their effectiveness in providing timely treatment options
Considered implications for antimicrobial use and patient outcomes
Rapid testing significantly decreased time to effective therapy (HR 0.75, 95% CI 0.60-0.90, p=0.02).
Patients receiving rapid testing had a 30% lower rate of progression to sepsis (OR 0.70, 95% CI 0.50-0.90, p=0.03).
Reduced unnecessary antimicrobial exposure by 25%, improving overall stewardship effectiveness.

No takes yet. Share an insight, caveat, or question.

Randomized trial evaluates rapid antimicrobial testing in bloodstream infections, suggesting improved therapy timing.

Nicoletti et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark